Vasodilator-Stimulated Phosphoprotein Regulates Proliferation and Growth Inhibition by Nitric Oxide in Vascular Smooth Muscle Cells
- 1 August 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 24 (8), 1403-1408
- https://doi.org/10.1161/01.atv.0000134705.39654.53
Abstract
Objective— Vasodilator-stimulated phosphoprotein (VASP) was identified as a substrate for cGMP-dependent protein kinase (PKG) and cAMP-dependent protein kinase (PKA). It is preferentially phosphorylated at serine239 by PKG, whereas serine157 is a preferred phosphorylation site for PKA. In addition, serine157 is phosphorylated by PKC in response to serum. We have investigated the effects of VASP and VASP phosphorylation at serine157 and serine239 on smooth muscle cell (SMC) proliferation and nitric oxide (NO)-mediated growth inhibition. Methods and Results— Aortic SMCs derived from VASP-deficient mice were transduced with retroviral vectors encoding either wild-type VASP or VASP mutants (S157A-VASP and S239A-VASP), in which serine157 and serine239, respectively, were replaced by a nonphosphorylatable amino acid, alanine. Expression of wt-VASP and S239A-VASP significantly increased proliferation, whereas expression of S157A-VASP was inhibitory. Expression of S239A-VASP rendered SMCs less sensitive to growth inhibition by the NO donor, S-nitroso-n-acetylpenicillamine, when compared with cells expressing wt-VASP. Similar effects were observed in cultured rat SMCs in which wt-VASP, S157A-VASP, and S239A-VASP were expressed. Conclusions— Our data suggest that VASP phosphorylation at serine157 is required for the growth-stimulatory effect of VASP in SMCs, whereas VASP phosphorylation at serine239 is involved in the growth inhibitory effects of NO on SMCs.Keywords
This publication has 45 references indexed in Scilit:
- Vasodilator-stimulated Phosphoprotein Activation of Serum-response Element-dependent Transcription Occurs Downstream of RhoA and Is Inhibited by cGMP-dependent Protein Kinase PhosphorylationPublished by Elsevier BV ,2004
- How VASP enhances actin-based motilityThe Journal of cell biology, 2003
- Critical Roles of Phosphorylation and Actin Binding Motifs, but Not the Central Proline-rich Region, for Ena/Vasodilator-stimulated Phosphoprotein (VASP) Function during Cell MigrationMolecular Biology of the Cell, 2002
- Phosphorylation of the Vasodilator-stimulated Phosphoprotein Regulates Its Interaction with ActinPublished by Elsevier BV ,2000
- Regulation of Human Endothelial Cell Focal Adhesion Sites and Migration by cGMP-dependent Protein Kinase IPublished by Elsevier BV ,2000
- Putting on the Brakes: A Negative Regulatory Function for Ena/VASP Proteins in Cell MigrationCell, 2000
- Ornithine Decarboxylase Is a Transcriptional Target of Tumor Suppressor WT1Experimental Cell Research, 1999
- Analysis and Regulation of Vasodilator-stimulated Phosphoprotein Serine 239 Phosphorylation in Vitro and in Intact Cells Using a Phosphospecific Monoclonal AntibodyPublished by Elsevier BV ,1998
- Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progressionCurrent Opinion in Cell Biology, 1997
- In vivo tyrosine phosphorylations of the abelson virus transforming protein are absent in its normal cellular homologCell, 1982